Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells)

被引:33
作者
Fujino, M
Li, XK
Kitazawa, Y
Guo, L
Kawasaki, M
Funeshima, I
Amano, T
Suzuki, S
机构
[1] Natl Childrens Med Res Ctr, Dept Expt Surg & Bioengn, Setagaya Ku, Tokyo, Japan
[2] Tokyo Univ Agr, Dept Zootech Sci, Tokyo, Japan
关键词
D O I
10.1124/jpet.300.3.939
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2-Amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY720), a synthetic product derived from a metabolite of Isaria sinclairii, has been demonstrated to have a potent immunosuppressive activity that induces apoptotic cell death in T cells and several other cell lines. In this study, using the human T-lymphoma cell line, Jurkat cells, we investigated the apoptotic, signal transduction mediated by FTY720, in particular comparing its role on the cleavage of caspases, with that mediated by etoposide or anti-Fas antibody. All of these agents cleaved caspases, inducing their active form in the affected cells. Pretreatment with a broad caspase inhibitor [benzyloxycarbonyl-Val-Ala-Asp-(Ome) fluoromethyl ketone] markedly decreased the incidence of apoptotic cells induced by FTY720, etoposide, and anti-Fas antibody, through the abrogation of cleavage of Bid, poly(ADP-ribose) polymerase, and caspases 3, 8, and 9. The overexpression of Bcl-2 gene prevented FTY720- and etoposide-mediated apoptosis, but not Fas-mediated apoptosis. In addition, mitochondria were demonstrated to play a critical role in FTY720-triggered cell death, suggesting that this drug has a potent anticancer activity.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 39 条
  • [1] DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-SUBSTITUTED-2-AMINO-1,3-PROPANEDIOLS - DISCOVERY OF A NOVEL IMMUNOSUPPRESSANT, FTY720
    ADACHI, K
    KOHARA, T
    NAKAO, N
    ARITA, M
    CHIBA, K
    MISHINA, T
    SASAKI, S
    FUJITA, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) : 853 - 856
  • [2] FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing
    Chiba, K
    Yanagawa, Y
    Kataoka, H
    Kawaguchi, T
    Ohtsuki, M
    Hoshino, Y
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1230 - 1233
  • [3] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [4] Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720
    Enosawa, S
    Suzuki, S
    Kakefuda, T
    Li, XK
    Amemiya, H
    [J]. IMMUNOPHARMACOLOGY, 1996, 34 (2-3): : 171 - 179
  • [5] In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains
    FernandesAlnemri, T
    Armstrong, RC
    Krebs, J
    Srinivasula, SM
    Wang, L
    Bullrich, F
    Fritz, LC
    Trapani, JA
    Tomaselli, KJ
    Litwack, G
    Alnemri, ES
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7464 - 7469
  • [6] Fujino M, 2001, XENOTRANSPLANTATION, V8, P115, DOI 10.1034/j.1399-3089.2001.00080.x
  • [7] Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
    Gross, A
    Yin, XM
    Wang, K
    Wei, MC
    Jockel, J
    Millman, C
    Erdjument-Bromage, H
    Tempst, P
    Korsmeyer, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) : 1156 - 1163
  • [8] KAUFMANN SH, 1993, CANCER RES, V53, P3976
  • [9] Proteolytic activities that mediate apoptosis
    Kidd, VJ
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 : 533 - 573
  • [10] Mitochondrial control of apoptosis
    Kroemer, G
    Zamzami, N
    Susin, SA
    [J]. IMMUNOLOGY TODAY, 1997, 18 (01): : 44 - 51